Avalo Therapeutics (AVTX) Stock Chart & Stock Price History $8.93 +0.58 (+6.95%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$9.03 +0.10 (+1.13%) As of 08/8/2025 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Avalo Therapeutics Stock Price Performance The Avalo Therapeutics (AVTX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 16.39%, with a year-to-date return of 20.19%. In the past month, the stock has increased 80.40%, reflecting recent market activity. As of the latest close, Avalo Therapeutics traded at $8.93 with a market cap of $96.69 million and volume of 392,428 shares. Receive AVTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Avalo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-0.45%1 Month Performance+80.40%3 Month Performance+119.95%Year-To-Date Performance+20.19%1 Year Performance-16.39% AVTX Stock Chart for Saturday, August, 9, 2025 AVTX Chart by TradingView Avalo Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/08/2025$8.35$8.93+6.95%$9.25$8.37392,428 shs$96.69 million08/07/2025$8.31$8.35+0.48%$8.79$8.01857,017 shs$90.43 million08/06/2025$8.20$8.31+1.34%$8.63$8.00186,632 shs$90.00 million08/05/2025$8.97$8.20-8.58%$9.20$7.871.55 million shs$88.81 million08/04/2025$7.89$8.97+13.69%$9.41$7.95247,363 shs$97.15 million08/01/2025$7.89$7.89$8.75$7.51242,138 shs$85.43 million07/31/2025$6.66$7.89+18.47%$7.96$6.57708,871 shs$85.45 million07/30/2025$6.54$6.66+1.83%$7.11$6.5156,833 shs$72.13 million07/29/2025$6.58$6.54-0.61%$6.80$6.2172,565 shs$70.82 million07/28/2025$6.69$6.58-1.64%$6.89$6.5859,982 shs$71.26 million Get the Latest News and Ratings for AVTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Avalo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/25/2025$6.63$6.69+0.90%$6.75$6.36112,659 shs$72.45 million07/24/2025$6.67$6.63-0.60%$6.74$6.5022,443 shs$71.80 million07/23/2025$6.42$6.67+3.89%$6.89$6.3487,888 shs$72.22 million07/22/2025$6.73$6.42-4.61%$6.93$6.4062,905 shs$69.53 million07/21/2025$6.25$6.73+7.68%$7.15$6.35114,930 shs$72.89 million07/18/2025$5.66$6.25+10.42%$6.50$5.50800,947 shs$67.69 million07/17/2025$4.85$5.66+16.70%$5.80$4.81377,850 shs$61.29 million07/16/2025$4.80$4.85+1.04%$4.95$4.8226,500 shs$52.53 million07/15/2025$4.90$4.80-2.04%$4.95$4.7232,067 shs$51.97 million07/14/2025$4.78$4.90+2.51%$4.95$4.7624,519 shs$53.06 million07/11/2025$4.90$4.78-2.45%$4.90$4.6140,254 shs$51.76 million07/10/2025$4.95$4.90-1.01%$4.96$4.8021,165 shs$53.07 million07/09/2025$4.85$4.95+2.06%$5.02$4.8252,735 shs$53.61 million07/08/2025$4.75$4.85+2.11%$4.99$4.6331,775 shs$52.53 million Related Companies Aura Biosciences Stock Chart Arcturus Therapeutics Stock Chart Abeona Therapeutics Stock Chart Nanobiotix Stock Chart Cartesian Therapeutics Stock Chart Rocket Pharmaceuticals Stock Chart Candel Therapeutics Stock Chart Amarin Stock Chart Inhibrx Biosciences Stock Chart Neurogene Stock Chart Receive AVTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Avalo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AVTX) was last updated on 8/9/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avalo Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avalo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AVTX Stock Alerts